Search
for
Sort by
Research 121–150 of 1000+
- Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Self-Amplifying RNA Approach for Protein Replacement Therapy
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- SARS‐COV2 Vaccination and Hidradenitis Suppurativa: Role of Vaccination in Disease Activity
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Integrin signalling regulates YAP/TAZ to control skin homeostasis
- Weakly supervised learning of biomedical information extraction from curated data
- Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- TREM2 macrophages induced by human lipids drive inflammation in acne lesions
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Lysophospholipid Mediators in Health and Disease
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- How drug repurposing can advance drug discovery: challenges and opportunities
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Anticancer effects of metformin on neuroendocrine tumor cells in vitro
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- New developments in the molecular treatment of ichthyosis: review of the literature
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)